The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila
- PMID: 19592113
- DOI: 10.1016/j.jinf.2009.06.008
The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila
Similar articles
-
Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S232-6. doi: 10.1086/591409. Clin Infect Dis. 2008. PMID: 18986295 Review.
-
Legionellosis.Semin Respir Crit Care Med. 2005 Dec;26(6):625-34. doi: 10.1055/s-2005-925526. Semin Respir Crit Care Med. 2005. PMID: 16388431 Review.
-
β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.JAMA Intern Med. 2014 Dec;174(12):1894-901. doi: 10.1001/jamainternmed.2014.4887. JAMA Intern Med. 2014. PMID: 25286173 Clinical Trial.
-
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.Int J Tuberc Lung Dis. 2010 Apr;14(4):495-9. Int J Tuberc Lung Dis. 2010. PMID: 20202309
-
Importance of atypical pathogens of community-acquired pneumonia.Clin Infect Dis. 2000 Aug;31 Suppl 2:S35-9. doi: 10.1086/314058. Clin Infect Dis. 2000. PMID: 10984326 Review.
Cited by
-
Are fluoroquinolones superior antibiotics for the treatment of community-acquired pneumonia?Curr Infect Dis Rep. 2012 Jun;14(3):317-29. doi: 10.1007/s11908-012-0251-y. Curr Infect Dis Rep. 2012. PMID: 22415582
-
The Diagnosis of Legionella pneumophila Serogroup 5 Bacteremic Pneumonia during Severe Neutropenia Using Loop-mediated Isothermal Amplification.Intern Med. 2018 Apr 1;57(7):1045-1048. doi: 10.2169/internalmedicine.9810-17. Epub 2017 Dec 21. Intern Med. 2018. PMID: 29269681 Free PMC article.
-
Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.Antimicrob Agents Chemother. 2017 Feb 23;61(3):e02188-16. doi: 10.1128/AAC.02188-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28069647 Free PMC article.
-
Legionnaires' Disease: Update on Diagnosis and Treatment.Infect Dis Ther. 2022 Jun;11(3):973-986. doi: 10.1007/s40121-022-00635-7. Epub 2022 May 3. Infect Dis Ther. 2022. PMID: 35505000 Free PMC article. Review.
-
Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.Clin Infect Dis. 2021 Jun 1;72(11):1979-1989. doi: 10.1093/cid/ciaa441. Clin Infect Dis. 2021. PMID: 32296816 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical